Jogeswar N. Mohapatra
Ahmedabad, GJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models.
Journal: Archives of microbiology
Published: June 08, 2026
Usnoflast: A cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology.
Journal: European journal of pharmacology
Published: April 16, 2025
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.
Journal: Pharmacology research & perspectives
Published: November 27, 2019
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells.
Journal: Haematologica
Published: April 11, 2019
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1.
Journal: Cancer chemotherapy and pharmacology
Published: May 05, 2018
Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).
Journal: Archives of virology
Published: October 09, 2016
Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice.
Journal: Journal of diabetes
Published: December 17, 2015
Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
Journal: Immunopharmacology and immunotoxicology
Published: June 21, 2014
Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: possible role of tissue inhibitor of metalloproteinase-3.
Journal: Indian journal of pharmacology
Published: May 05, 2014
Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation.
Journal: Cytokine
Published: September 13, 2013
Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis.
Journal: International immunopharmacology
Published: April 17, 2013
Last Updated: 09/26/2026